(Astellas’ material issues) and then classify them into three  categories depending on their materiality by evaluating  their social significance and relevance to our business.  Based on this materiality and the attainment level of our  initiatives, we determine the concrete actions to be  addressed with priority. In fiscal 2013, we identified material issues by reflect- ing views from a more expansive range of perspectives  than before, by conducting stakeholder dialogue to  incorporate feedback from outside the Company as well  as encouraging participation from our global employees. For more details, please refer to http://www.astellas.com/en/csr/management/issues.html Business Strategy Societal benefit-driven product development Affordable pricing for patients Improvement of healthcare infrastructure and services to solve ATH* issues CSR procurement Socially responsible manufacturing Recruitment and retention of employees Stakeholder engagement Information disclosure Development of innovative products Socially responsible R&D Socially responsible marketing and ethical advertising Fair pricing Proper use of products Product quality assurance Anti-counterfeit efforts Diversity and equal opportunity Training and development of employees Health, safety and welfare of employees Compliance with laws and regulations Business ethics and fair competition Establishment and implementation of CSR Policies Customer privacy Shareholder engagement Transparent reporting of Board independence and its structure Universal design for products Customer satisfaction Reduction of environmental impact throughout lifecycle of our products Environmental and social impacts of business operations Climate change risk Compensation and benefits Labor relations and union practices Risk mitigation and immediate remedy of environmental accidents Efficient use of energy and reduction of greenhouse gas emissions Waste management and hazardous water reduction Patient assistance and advocacy Advancement of medical science Disclosure of executive compensation Appropriate lobbying and political contributions * ATH: Astellas refers to two problems as the “Access to Health” (ATH) issues, one is the existence of many therapeutic areas with unmet medical needs and the other is the existence of many people who are unable to access the healthcare they need due to such reasons as poverty and healthcare system flaws. Annual Report 2014 _  Astellas Pharma Inc.  31 very High relevance to Astellas’ business Most Important Very Important Important